ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis
Fibrogenic progression of chronic liver disease, whatever the etiology, is characterized by persistent chronic parenchymal injury, chronic activation of inflammatory response, and sustained activation of liver fibrogenesis, and of pathological wound healing response. A critical role in liver fibroge...
Main Authors: | Beatrice Foglia, Stefania Cannito, Claudia Bocca, Maurizio Parola, Erica Novo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/11/2700 |
Similar Items
-
Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts
by: Norifumi eKawada
Published: (2015-11-01) -
Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
by: Oliver Krenkel, et al.
Published: (2019-05-01) -
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
by: Bedair Dewidar, et al.
Published: (2019-11-01) -
The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies.
by: Jun eXu, et al.
Published: (2014-07-01) -
Myofibroblasts in Schistosomal Portal Fibrosis of Man
by: Andrade Zilton A, et al.
Published: (1999-01-01)